Department of Convergence Medicine, College of Medicine, Korea University, Seoul, South Korea.
Department of Bionanosystem Engineering, Graduate School, Jeonbuk National University, Jeonju, South Korea.
Biomed Eng Online. 2024 Nov 27;23(1):121. doi: 10.1186/s12938-024-01312-1.
Acute ischemic stroke (AIS) remains a major cause of morbidity and mortality worldwide. Mechanical thrombectomy, especially with stent retrievers, offers a promising treatment, particularly for patients ineligible for intravenous tissue plasminogen activator (IV tPA) therapy. This study aimed to develop and evaluate novel stent retriever designs to enhance mechanical properties and vessel compatibility.
We evaluated four stent designs using finite-element analysis (FEA) to assess their mechanical properties. Based on these evaluations, Stent D emerged as the optimal design due to its superior elasticity and adaptability. Comparative testing of Stent D against commercial stents, Solitaire FR and Trevo XP ProVue, revealed the following metrics: radial forces of 3.77 ± 0.01 N for Solitaire FR, 3.92 ± 0.08 N for Trevo XP ProVue, and 4.10 ± 0.07 N for Stent D; flexibility measurements of 0.38 ± 0.11 N for Solitaire FR, 0.91 ± 0.11 N for Trevo XP ProVue, and 0.59 ± 0.05 N for Stent D; deployment forces of 0.37 ± 0.02 N for Solitaire FR, 0.42 ± 0.04 N for Trevo XP ProVue, and 0.32 ± 0.02 N for Stent D; and recapture forces of 0.38 ± 0.01 N for Solitaire FR, 0.45 ± 0.02 N for Trevo XP ProVue, and 0.35 ± 0.01 N for Stent D. Thrombus retrieval rates were 96.16% for Solitaire FR and 95.51% for Stent D.
These findings demonstrate that Stent D performs comparably to commercial stents, highlighting its effective performance in AIS treatment. Stent D shows promise as a candidate for further clinical evaluation due to its superior mechanical properties and effective thrombus retrieval capabilities.
急性缺血性脑卒中(AIS)仍然是全球发病率和死亡率的主要原因。机械血栓切除术,特别是使用支架取栓器,为患者提供了一种很有前途的治疗方法,特别是对不适合静脉注射组织型纤溶酶原激活剂(IV tPA)治疗的患者。本研究旨在开发和评估新型支架取栓器设计,以增强机械性能和血管相容性。
我们使用有限元分析(FEA)评估了四种支架设计,以评估它们的机械性能。基于这些评估,支架 D 由于其卓越的弹性和适应性而成为最佳设计。支架 D 与商业支架 Solitaire FR 和 Trevo XP ProVue 的比较测试显示了以下指标:Solitaire FR 的径向力为 3.77±0.01 N,Trevo XP ProVue 的径向力为 3.92±0.08 N,支架 D 的径向力为 4.10±0.07 N;Solitaire FR 的柔韧性测量值为 0.38±0.11 N,Trevo XP ProVue 的柔韧性测量值为 0.91±0.11 N,支架 D 的柔韧性测量值为 0.59±0.05 N;Solitaire FR 的展开力为 0.37±0.02 N,Trevo XP ProVue 的展开力为 0.42±0.04 N,支架 D 的展开力为 0.32±0.02 N;Solitaire FR 的再捕获力为 0.38±0.01 N,Trevo XP ProVue 的再捕获力为 0.45±0.02 N,支架 D 的再捕获力为 0.35±0.01 N。Solitaire FR 的血栓回收率为 96.16%,支架 D 的血栓回收率为 95.51%。
这些发现表明,支架 D 的性能与商业支架相当,突出了其在 AIS 治疗中的有效性能。支架 D 因其卓越的机械性能和有效的血栓提取能力,有望成为进一步临床评估的候选者。